Summary
Latest filing:
Sandra M. Gurrola is Sr. VP of Finance of Ernexa Therapeutics Inc. (ERNA). 1 SEC Form 4 filing on record, dated 21 June 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Sandra M. Gurrola has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sandra M. Gurrola files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Charles Cherington - $2.00M of ERNA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sandra M. Gurrola?
Sandra M. Gurrola is a corporate insider, tracked as Sr. VP of Finance of Ernexa Therapeutics Inc. (ERNA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sandra M. Gurrola last file a Form 4?
The only primary Form 4 on record is dated 21 June 2025.
Where can I see all of Sandra M. Gurrola's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sandra M. Gurrola and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
